BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6343648)

  • 21. Cellular immune responses of human milk T lymphocytes to certain environmental antigens.
    Parmely MJ; Reath DB; Beer AE; Billingham RE
    Transplant Proc; 1977 Jun; 9(2):1477-83. PubMed ID: 69346
    [No Abstract]   [Full Text] [Related]  

  • 22. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE; Schein MF; Hall CA; Barnes SA
    Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed hypersensitivity to tetanus toxoid in man: in vivo and in vitro studies.
    Johnson C; Walls RS; Ruwoldt A
    Pathology; 1983 Oct; 15(4):369-72. PubMed ID: 6674868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed hypersensitivity to tuberculin and other antigens in a hospital population.
    Walls RS
    S Afr Med J; 1974 Oct; 48(49):2073-6. PubMed ID: 4609390
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo and in vitro cell-mediated immunity to tetanus toxoid in adults.
    Fairshter RD; Thornton DB; Gottschalk HR; Slater LM; Galant SP
    J Allergy Clin Immunol; 1980 Dec; 66(6):452-7. PubMed ID: 7430503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric case series evaluating a standardized Candida albicans skin test product.
    Ohri LK; Manley JM; Chatterjee A; Cornish NE
    Ann Pharmacother; 2004 Jun; 38(6):973-7. PubMed ID: 15084686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cynomolgus monkeys (Macaca fascicularis) in preclinical immune function safety testing: development of a delayed-type hypersensitivity procedure.
    Bleavins MR; de la Iglesia FA
    Toxicology; 1995 Jan; 95(1-3):103-12. PubMed ID: 7825177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of aging and acute illness on delayed hypersensitivity.
    Grossman J; Baum J; Gluckman J; Fusner J; Condemi JJ
    J Allergy Clin Immunol; 1975 Apr; 55(4):268-75. PubMed ID: 235584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intracutaneous tests with phytohemagglutinin for detection of cell-mediated immunity (author's transl)].
    Westphal HJ; Kaben U
    Allerg Immunol (Leipz); 1979; 25(4):275-80. PubMed ID: 161949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients.
    Kilian HD; Nielsen G
    Trop Med Parasitol; 1989 Sep; 40(3):285-91. PubMed ID: 2617034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of delayed hypersensitivity: from PPD to poison ivy.
    Rosenstreich DL
    Allergy Proc; 1993; 14(6):395-400. PubMed ID: 8157162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in response to the multitest CMI skin test in the general population.
    Vine MF; Stein L; Weigle K
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):445-50. PubMed ID: 10795654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens.
    Remitz A; Lauerma AI; Erkko P; Reitamo S
    Acta Derm Venereol; 1996 Jul; 76(4):310-3. PubMed ID: 8869692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population.
    Palmer DL; Reed WP
    J Infect Dis; 1974 Aug; 130(2):132-7. PubMed ID: 4842904
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed hypersensitivity skin testing for assessing anergy in the mid-south.
    Stimpson PG; Paty JG; Hudson T; Lieberman P
    South Med J; 1976 Apr; 69(4):424-6. PubMed ID: 1265500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
    Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
    Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed hypersensitivity skin testing of 150 volunteers. Retesting results and antibody measurements.
    Neuvonen P; Salo M; Viljanen M; Helander I
    Allergy; 1985 Apr; 40(3):208-12. PubMed ID: 3993871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.